European Dividend Aristocrat Novartis raises 2022 by 3.2% to record CHF 3.20
Swiss pharmaceutical company Novartis , one of only a handful of real European Dividend Aristocrats, will raise its dividend for the 26th consecutive year in 2023.
Posts
Showing posts with the label Novartis